Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05JRZ
|
||||
| Former ID |
DNC006829
|
||||
| Drug Name |
NSC-27236
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [528283] | ||
| Formula |
C13H11N3O5S
|
||||
| Canonical SMILES |
C1=CC(=CC=C1NN=C2C=CC(=O)C(=C2)C(=O)O)S(=O)(=O)N
|
||||
| InChI |
1S/C13H11N3O5S/c14-22(20,21)10-4-1-8(2-5-10)15-16-9-3-6-12(17)11(7-9)13(18)19/h1-7,15H,(H,18,19)(H2,14,20,21)/b16-9-
|
||||
| InChIKey |
BLGKPMXPJZAYFD-SXGWCWSVSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Prostaglandin G/H synthase 2 | Target Info | Inhibitor | [528283] | |
| KEGG Pathway | Arachidonic acid metabolism | ||||
| Metabolic pathways | |||||
| NF-kappa B signaling pathway | |||||
| VEGF signaling pathway | |||||
| TNF signaling pathway | |||||
| Retrograde endocannabinoid signaling | |||||
| Serotonergic synapse | |||||
| Ovarian steroidogenesis | |||||
| Oxytocin signaling pathway | |||||
| Regulation of lipolysis in adipocytes | |||||
| Leishmaniasis | |||||
| Pathways in cancer | |||||
| Chemical carcinogenesis | |||||
| MicroRNAs in cancer | |||||
| Small cell lung cancer | |||||
| PathWhiz Pathway | Arachidonic Acid Metabolism | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.